A phase I study of busulfan consolidation/intensification therapy for patients with high risk acute myeloid leukemia (AML).

@article{Gharibo2006API,
  title={A phase I study of busulfan consolidation/intensification therapy for patients with high risk acute myeloid leukemia (AML).},
  author={Mecide Meric Gharibo and Dale G Schaar and Arnold D. Rubin and Stephanie L Grospe and Liesel Dudek and Roger Strair},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 18_suppl},
  pages={6580}
}
6580 Background: Elderly AML patients have a poor prognosis. More effective well-tolerated treatments are needed to improve outcomes. Busulfan is an effective anti-leukemia drug commonly used in transplant regimens. We designed a phase I dose escalation study of single dose busulfan as consolidation/intensification therapy for elderly patients with AML… CONTINUE READING